Warszawski Uniwersytet Medyczny

At Warszawski Uniwersytet Medyczny, clinical research in these areas focuses on rare and inherited conditions, especially glycogenosis type Ib. The trials are designed to assess whether a new treatment approach can help manage disease-related complications while supporting overall metabolic health.

• Studying glycogenosis type Ib and its impact on neutropenia
• Evaluating a potential therapy for improving safety and tolerability in this rare disease
• Exploring links between immune function and metabolic disorders

This work reflects a strong interest in metabolism and immune-related disease, with a clear focus on improving care for patients with uncommon but serious conditions.

Research at this medical university also examines how early vaccination may influence the future risk of type 1 diabetes in children with elevated genetic susceptibility. The goal is to better understand whether infection prevention can help reduce autoimmune disease development.

• Following children at increased genetic risk for type 1 diabetes
• Assessing the role of COVID-19 vaccination in early immune protection
• Testing whether vaccination may lower the chance of autoantibody formation

This line of research connects viral disease prevention with public health and early-life disease prevention, aiming to improve long-term outcomes through better understanding of immune risk.